Literature DB >> 24900260

Structure-based ligand design of novel bacterial RNA polymerase inhibitors.

Martin J McPhillie1, Rachel Trowbridge1, Katherine R Mariner1, Alex J O'Neill1, A Peter Johnson1, Ian Chopra1, Colin W G Fishwick1.   

Abstract

Bacterial RNA polymerase (RNAP) is essential for transcription and is an antibacterial target for small molecule inhibitors. The binding region of myxopyronin B (MyxB), a bacterial RNAP inhibitor, offers the possibility of new inhibitor design. The molecular design program SPROUT has been used in conjunction with the X-ray cocrystal structure of Thermus thermophilus RNAP with MyxB to design novel inhibitors based on a substituted pyridyl-benzamide scaffold. A series of molecules, with molecular masses <350 Da, have been prepared using a simple synthetic approach. A number of these compounds inhibited Escherichia coli RNAP.

Entities:  

Keywords:  Bacterial RNA polymerase; myxopyronin B; small molecule inhibitors; structure-based ligand discovery

Year:  2011        PMID: 24900260      PMCID: PMC4017976          DOI: 10.1021/ml200087m

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  22 in total

Review 1.  Research and development of antibacterial agents.

Authors:  I Chopra
Journal:  Curr Opin Microbiol       Date:  1998-10       Impact factor: 7.934

Review 2.  New inhibitors targeting bacterial RNA polymerase.

Authors:  Seth A Darst
Journal:  Trends Biochem Sci       Date:  2004-04       Impact factor: 13.807

Review 3.  Antibacterial drug discovery and structure-based design.

Authors:  John J Barker
Journal:  Drug Discov Today       Date:  2006-05       Impact factor: 7.851

Review 4.  Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Authors:  David J Payne; Michael N Gwynn; David J Holmes; David L Pompliano
Journal:  Nat Rev Drug Discov       Date:  2006-12-08       Impact factor: 84.694

5.  Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase.

Authors:  Ricardo Lira; Alan X Xiang; Thomas Doundoulakis; William T Biller; Konstantinos A Agrios; Klaus B Simonsen; Stephen E Webber; Wes Sisson; Robert M Aust; Amit M Shah; Richard E Showalter; Virginia N Banh; Kevin R Steffy; James R Appleman
Journal:  Bioorg Med Chem Lett       Date:  2007-10-17       Impact factor: 2.823

6.  A guide to sensitivity testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy.

Authors: 
Journal:  J Antimicrob Chemother       Date:  1991-06       Impact factor: 5.790

7.  SPROUT: a program for structure generation.

Authors:  V Gillet; A P Johnson; P Mata; S Sike; P Williams
Journal:  J Comput Aided Mol Des       Date:  1993-04       Impact factor: 3.686

8.  Transcription inactivation through local refolding of the RNA polymerase structure.

Authors:  Georgiy A Belogurov; Marina N Vassylyeva; Anastasiya Sevostyanova; James R Appleman; Alan X Xiang; Ricardo Lira; Stephen E Webber; Sergiy Klyuyev; Evgeny Nudler; Irina Artsimovitch; Dmitry G Vassylyev
Journal:  Nature       Date:  2008-10-22       Impact factor: 49.962

9.  The RNA polymerase "switch region" is a target for inhibitors.

Authors:  Jayanta Mukhopadhyay; Kalyan Das; Sajida Ismail; David Koppstein; Minyoung Jang; Brian Hudson; Stefan Sarafianos; Steven Tuske; Jay Patel; Rolf Jansen; Herbert Irschik; Eddy Arnold; Richard H Ebright
Journal:  Cell       Date:  2008-10-17       Impact factor: 41.582

Review 10.  Structures of RNA polymerase-antibiotic complexes.

Authors:  Mary X Ho; Brian P Hudson; Kalyan Das; Eddy Arnold; Richard H Ebright
Journal:  Curr Opin Struct Biol       Date:  2009-11-18       Impact factor: 6.809

View more
  3 in total

1.  Cyclopropyl-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5.

Authors:  Sirish K Lakkaraju; Hannah Mbatia; Marie Hanscom; Zaorui Zhao; Junfang Wu; Bogdan Stoica; Alexander D MacKerell; Alan I Faden; Fengtian Xue
Journal:  Bioorg Med Chem Lett       Date:  2015-04-20       Impact factor: 2.823

2.  Novel hybrid-type antimicrobial agents targeting the switch region of bacterial RNA polymerase.

Authors:  Fumika Yakushiji; Yuko Miyamoto; Yuki Kunoh; Reiko Okamoto; Hidemasa Nakaminami; Yuri Yamazaki; Norihisa Noguchi; Yoshio Hayashi
Journal:  ACS Med Chem Lett       Date:  2013-01-11       Impact factor: 4.345

3.  De novo design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding region.

Authors:  Kyle M Orritt; Lipeng Feng; Juliette F Newell; Jack N Sutton; Scott Grossman; Thomas Germe; Lauren R Abbott; Holly L Jackson; Benjamin K L Bury; Anthony Maxwell; Martin J McPhillie; Colin W G Fishwick
Journal:  RSC Med Chem       Date:  2022-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.